Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 October 2023 | Story Carmenita Redcliffe-Paul

The University of the Free State (UFS) and the South African Chamber of Commerce United Kingdom (SACC UK) are pleased to invite you to the next conversation of the Global Citizen Series.

SACC UK representative, Director of Mindofafox, futurist, and bestselling author, Chantell Ilbury, will facilitate this thought-provoking and engaging conversation between UFS Vice-Chancellor and Principal, Prof Francis Petersen, and President and Chief Executive of the International Council on Mining and Metals (ICMM), Rohitesh Dhawan.

The discussion will explore the strategic priorities and breakthroughs in the mining and metals industry in relation to critical areas of climate and environmental resilience, social performance, governance, ethics and transparency, and innovation for sustainability. 

Dhawan, a Fellow and faculty member of the Africa Leadership Initiative, will reflect on leadership through collaboration to enhance the contribution of mining and metals towards sustainable development, security of minerals within a changing geopolitical environment and the progress that is possible when citizens collectively focus on improving the lives of others and our planet.

Participate in the Global Citizen event in person or online via live stream. 

Kindly RSVP on the links below and indicate your preferred method of participation.

Join the Global Citizen in person in London, United Kingdom

Date: Wednesday, 8 November 2023 
Time: 17:30-19:30
Venue: SOAS Brunei Gallery – SOAS, University of London, Thornhaugh Street, Russell Sq, London WC1B 5DQ, United Kingdom
RSVP: Friday, 27 October 2023 
Enquiries: Adrienne Hall E: adrienne@creative-partnerships.co.uk or T: +44 7469 219157

Light refreshments will be served after the event.

Join the Global Citizen event online

Date: Wednesday, 8 November 2023 
SA time 20:00-21:00 SAST
UK time 18:00-19:00 GMT
RSVP here by Friday, 3 November 2023 

The live stream link will be shared upon RSVP.

About Rohitesh Dhawan

Rohitesh Dhawan was appointed President and Chief Executive Officer of ICMM in April 2021. He is passionate about the transformative power of mining, particularly in emerging markets where he has spent two-thirds of his life. Dhawan is a Fellow and faculty member of the Africa Leadership Initiative and a Raisina fellow of the Asian Forum on Global Governance. He serves on the advisory boards of the Columbia Centre on Sustainable Investment, Concordia, and Resolve.  

Read more about Rohitesh Dhawan here.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept